infect
adher
cell
monolay
use
liquid
inoculum
repres
establish
method
reliabl
quantit
studi
viru
infect
poorli
recapitul
exposur
infect
cell
respiratori
tract
occur
infect
aerosol
pathogen
better
simul
natur
infect
vitro
adapt
system
gener
viral
aerosol
similar
exhal
infect
human
inocul
epitheli
cell
monolay
procedur
cellular
infect
calcul
exposur
dose
develop
test
use
virus
character
distinct
transmiss
pathogen
phenotyp
hpai
lpai
season
viru
three
aerosol
virus
highli
infecti
human
bronchial
epitheli
cell
line
cultur
submerg
media
differ
virus
observ
primari
human
alveolar
epitheli
cell
cell
cultur
airliquid
interfac
system
provid
novel
enhanc
tradit
vitro
experi
particularli
focus
earli
stage
infect
infect
adher
cell
monolay
use
liquid
inoculum
repres
establish
method
reliabl
quantit
studi
viru
infect
rel
straightforward
inexpens
method
allow
frequent
collect
viral
sampl
test
varieti
experiment
condit
discret
cell
type
includ
human
origin
unfortun
tradit
vitro
replic
studi
poorli
recapitul
exposur
infect
cell
respiratori
tract
occur
natur
exposur
aerosol
pathogen
infect
occur
cell
apic
surfac
immers
liquid
typic
cell
densiti
oftenus
low
multipl
infect
moi
correspond
dose
thousand
pfu
per
squar
centimet
avail
evid
suggest
case
aerosol
transmiss
natur
human
influenza
infect
like
initi
substanti
fewer
particl
studi
infect
patient
found
low
viral
concentr
aerosol
gener
breath
cough
andor
sneez
fabian
et
al
milton
et
al
yang
et
al
fewer
five
tcid
capabl
initi
symptomat
infect
experiment
expos
volunt
alford
et
al
similar
result
observ
ferret
model
anim
infect
fewer
ten
pfu
subsequ
exhal
five
pfu
per
minut
gustin
et
al
gustin
et
al
robert
et
al
use
librari
barcod
virus
varbl
et
al
found
respiratori
droplet
transmiss
ferret
involv
singledigit
number
virion
varbl
et
al
report
case
develop
subsequ
patient
visit
live
bird
market
despit
lack
poultri
contact
detect
viru
air
sampl
market
indic
zoonot
infect
may
also
occur
human
exposur
low
quantiti
aerosol
viru
li
et
al
liu
et
al
zhou
et
al
order
better
studi
effect
potenti
damag
aerosol
human
cell
toxicolog
field
begun
expos
cultur
respiratori
epitheli
cell
aerosol
rather
liquidsuspend
chemic
particul
matter
cell
shown
sensit
effect
former
bitterl
et
al
raemi
et
al
studi
aerosol
concentr
measur
use
optic
gravimetr
method
type
method
effect
measur
viruscontain
aerosol
howev
detect
liquid
droplet
nuclei
rather
viru
within
differenti
infecti
noninfecti
virion
microbiologist
develop
aerosol
system
overcom
challeng
use
experiment
infect
anim
studi
effect
environment
condit
viabil
numer
pathogen
includ
mycobacterium
tuberculosi
bacillu
anthraci
measl
viru
influenza
viru
clark
et
al
gustin
et
al
lemon
et
al
savranski
et
al
work
provid
import
insight
intraand
interhost
spread
pathogen
facilit
observ
manipul
nearnatur
infect
within
control
laboratori
environ
howev
despit
frequent
employ
vitro
studi
complement
anim
experiment
use
aerosol
system
vitro
infect
pathogen
knowledg
previous
describ
combin
aspect
toxicolog
microbiolog
approach
establish
novel
method
expos
adher
mammalian
cell
monolay
airliquid
interfac
defin
quantiti
aerosol
influenza
viru
compar
tradit
liquid
inocul
order
effect
mimic
condit
natur
infect
explor
use
low
moi
infect
cultur
techniqu
design
promot
cell
differenti
conjunct
viru
aerosol
use
highli
pathogen
avian
influenza
hpai
low
pathogen
avian
influenza
lpai
season
influenza
virus
demonstr
infect
respiratori
epitheli
cell
physiolog
low
concentr
aerosol
viru
success
recreat
insid
laboratori
conjunct
research
use
anim
model
techniqu
facilit
closer
studi
infect
aerosol
influenza
viru
context
human
infect
approach
describ
restrict
influenza
viru
would
also
applic
studi
respiratori
virus
public
health
concern
materi
method
influenza
virus
propag
allanto
caviti
embryon
hen
egg
titer
via
standard
plaqu
assay
use
madindarbi
canin
kidney
mdck
cell
previous
describ
main
et
al
zeng
et
al
experi
conduct
biosafeti
level
contain
includ
enhanc
requir
us
depart
agricultur
feder
select
agent
program
chosewood
et
al
bronchial
epitheli
cell
line
atcc
cultur
previous
describ
zeng
et
al
primari
human
alveolar
epitheli
cell
cell
biolog
cryopreserv
passag
grown
expand
per
manufactur
instruct
cell
seed
mm
diamet
format
mm
diamet
format
semiperm
membran
insert
pore
size
corn
grown
confluenc
submerg
condit
depict
human
cell
cultur
transwel
insert
expos
aerosol
influenza
viru
use
previous
character
system
gustin
et
al
cell
cultur
dish
rest
exposur
chamber
wire
shelf
airliquid
interfac
condit
durat
exposur
inset
individu
transwel
insert
transfer
steril
plate
remov
exposur
chamber
hm
creager
et
al
virolog
reach
transepitheli
resist
zeng
et
al
apic
media
remov
select
cell
creat
airliquid
interfac
ali
maintain
three
week
facilit
cell
differenti
establish
mucin
layer
prior
inocul
apic
media
present
remov
cell
monolay
cell
cultur
submerg
condit
wash
remov
serum
present
cultur
medium
liquid
inocul
perform
use
viru
dilut
specifi
result
incub
cell
surfac
one
hour
wash
infect
cell
cultur
cell
typespecif
serumfre
medium
chloromethyl
keton
tpck
treat
trypsin
sigmaaldrich
ad
alveolar
cell
cultur
aliquot
apic
cultur
supernat
wash
media
incub
atop
cell
cultur
ali
min
collect
indic
time
postinfect
pi
immedi
frozen
titrat
growth
curv
gener
analyz
use
prism
graphpad
softwar
inc
autom
bioaerosol
system
use
experi
previous
describ
detail
gustin
et
al
hart
roy
condit
maintain
unless
specifi
otherwis
briefli
viru
suspend
solut
wv
bsa
aerosol
use
threejet
collis
nebul
bgi
inc
pass
exposur
chamber
rate
lmin
cell
place
insid
exposur
chamber
wire
mesh
shelf
inocul
airliquid
interfac
condit
fig
use
aeromp
biaera
technolog
aerosol
manag
platform
aerosol
exposur
conduct
rel
humid
min
follow
min
purg
allow
evacu
aerosol
viru
chamber
gustin
et
al
prior
vitro
exposur
spray
factor
sf
valu
determin
stock
virus
estim
start
viru
concentr
nebul
need
obtain
desir
concentr
viru
aerosol
biosampl
skc
inc
use
quantifi
viru
actual
aerosol
within
chamber
exposur
follow
aerosol
exposur
membran
insert
transfer
clean
plate
serumfre
medium
ad
apic
basolater
compart
describ
cell
maintain
ali
condit
medium
ad
basolater
compart
confirm
cell
viabil
aerosol
exposur
perform
use
cell
prolifer
reagent
roch
appli
scienc
accord
manufactur
instruct
four
independ
sampl
test
condit
total
number
infecti
virion
pass
chamber
exposur
session
n
cham
calcul
c
samp
concentr
viru
sampler
v
samp
volum
media
sampler
q
cham
q
samp
repres
flow
rate
chamber
sampler
respect
see
supplement
method
deriv
n
cham
multipli
ratio
surfac
area
transwel
sa
crosssect
area
chamber
xa
yield
exposur
dose
ed
id
calcul
accord
method
reed
muench
proport
distanc
multipli
log
dose
log
dose
account
deviat
exposur
dose
exact
dilut
reed
muench
variabl
around
mean
exposur
dose
quantifi
use
binomi
model
n
viabl
virion
pass
chamber
probabl
success
virion
land
well
equal
saxa
upper
lower
critic
valu
confid
level
calcul
use
r
r
foundat
statist
comput
true
exposur
dose
particular
well
chanc
fall
two
valu
cumul
probabl
distribut
indic
minimum
dose
three
greater
well
inocul
least
one
virion
order
minim
chanc
includ
well
expos
viru
therefor
aim
use
mean
exposur
dose
pfu
occur
due
variat
aerosol
effici
minimum
infecti
dose
report
pfu
total
rna
extract
mockinfect
virusinfect
cell
monolay
remov
supernat
use
rneasi
mini
kit
qiagen
rtpcr
perform
quantitect
sybr
green
rtpcr
kit
qiagen
duplic
reaction
duplic
sampl
use
influenza
viru
gene
primer
set
zeng
et
al
influenza
viru
gene
rna
copi
number
extrapol
use
standard
curv
base
sampl
known
gene
copi
number
rather
use
type
exposur
system
describ
studi
cellular
respons
aerosol
particul
matter
eg
cultex
radial
flow
system
employ
one
intend
use
anim
infect
previous
optim
use
influenza
viru
gustin
et
al
system
compon
design
maintain
viabil
biolog
aerosol
system
featur
larg
exposur
chamber
allow
simultan
exposur
sever
plate
cell
facilit
comparison
differ
cell
type
growth
condit
uniformli
expos
well
fig
vitro
inocul
cell
grown
semiperm
membran
insert
transwel
conduct
follow
apic
media
present
remov
immedi
prior
exposur
plate
hold
insert
basolater
media
place
chamber
expos
tenfold
serial
dilut
aerosol
viru
durat
min
follow
exposur
insert
transfer
steril
tissu
cultur
plate
contain
fresh
basolater
media
apic
media
replac
mock
infect
led
signific
decreas
cell
viabil
data
shown
indic
presenc
basolater
media
suffici
keep
cell
dri
exposur
abil
quantit
dose
anim
cell
monolay
expos
critic
compon
experi
util
aerosolbas
exposur
system
hart
roy
necessari
comparison
aerosol
infect
conduct
tradit
liquid
rout
found
titrat
viru
collect
well
media
place
chamber
alongsid
cell
insuffici
sensit
reliabl
quantifi
low
dose
monolay
expos
data
shown
possibl
deposit
effici
differ
cell
surfac
liquid
media
therefor
model
approach
use
aerosol
inocul
anim
present
dose
anim
express
total
number
infecti
virion
pass
chamber
exposur
session
multipli
ratio
volum
aerosol
inhal
anim
total
volum
aerosol
pass
chamber
see
supplement
method
deriv
vitro
quantif
substitut
ratio
surfac
area
transwel
insert
crosssect
area
chamber
ratio
inhal
total
aerosol
volum
effici
particl
deposit
cell
surfac
estim
approxim
present
dose
exposur
dose
consid
equival
correl
plate
posit
within
chamber
well
posit
within
plate
virolog
outcom
observ
initi
character
studi
conduct
use
human
bronchial
epitheli
cell
line
cell
type
relev
respiratori
infect
previous
shown
support
replic
varieti
influenza
virus
though
publish
studi
typic
use
moi
equival
tcid
pfu
per
mm
well
higher
zeng
et
al
zhou
et
al
order
gener
comparison
data
aerosol
infect
first
conduct
analog
experi
use
tradit
liquid
inocul
wide
rang
dose
two
influenza
virus
known
replic
high
effici
hpai
lpai
isol
fatal
human
case
serial
dilut
use
inocul
quintupl
well
potenti
random
system
error
make
repeat
serial
dilut
titrat
inocula
enabl
us
precis
estim
number
infecti
virion
well
expos
rna
collect
cell
monolay
two
well
h
postinocul
assay
presenc
viral
nucleic
acid
via
rtpcr
primer
specif
gene
growth
kinet
remain
three
well
monitor
titrat
cell
supernat
collect
h
postinfect
fig
inoculum
dose
limit
detect
pfuml
pfuwel
virus
consist
infect
replic
well
replic
high
titer
though
growth
somewhat
delay
lower
inocul
dose
rel
higher
one
fig
also
observ
robust
replic
cultur
inocul
approxim
pfu
dose
estim
serial
dilut
viru
dose
less
one
pfu
infect
infrequ
character
low
titer
undetect
level
viral
nucleic
acid
cell
monolay
h
inocul
aerosol
experi
conduct
three
virus
chosen
repres
divers
mammalian
vivo
pathogen
transmiss
phenotyp
season
three
virus
infect
cell
high
effici
follow
aerosol
exposur
fig
observ
rate
product
infect
compar
seen
inocul
use
liquid
suspens
infecti
dose
id
three
virus
five
pfu
high
peak
viral
titer
pfuml
detect
supernat
regardless
exposur
dose
though
liquid
inoculum
replic
delay
lower
inocul
dose
fig
parallel
cultur
incub
postexposur
temperatur
thought
repres
mammalian
upper
respiratori
tract
infect
see
whether
infect
temperaturedepend
found
titer
two
avian
virus
slightli
lower
temperatur
infect
cultur
reduc
viru
slightli
id
vs
pfu
concord
infecti
dose
aerosol
liquid
inocul
suggest
calcul
exposur
dose
well
accur
repres
averag
number
virion
well
truli
expos
confirm
conduct
seri
exposur
dose
near
pfu
rang
pfu
per
well
light
liquid
exposur
data
reason
calcul
exposur
dose
accur
major
well
infect
either
virus
dose
pfu
wherea
well
would
infect
dose
pfu
consist
infect
calcul
dose
pfu
would
indic
true
exposur
dose
higher
calcul
one
convers
infrequ
infect
dose
pfu
would
suggest
actual
exposur
dose
less
calcul
one
order
conduct
quantit
analysi
determin
number
well
would
expect
becom
infect
set
exposur
use
poisson
binomi
model
hong
statist
compar
expect
number
infect
well
base
calcul
exposur
dose
number
well
observ
infect
experi
reflect
actual
exposur
dose
tabl
even
though
test
highli
power
chanc
detect
halflog
differ
true
calcul
exposur
dose
differ
present
detect
differ
either
virus
test
p
suggest
estim
deposit
effici
compromis
exposur
dose
estim
valid
methodolog
use
transform
cell
line
next
investig
abil
lowdos
aerosol
infect
primari
human
alveolar
epitheli
cell
season
influenza
virus
typic
restrict
upper
respiratori
tract
infect
human
mammalian
model
avian
virus
often
detect
lung
howev
multipl
vitro
studi
found
primari
human
alveolar
cell
permiss
replic
human
influenza
virus
weinheim
et
al
yu
et
al
hypothes
discrep
might
artifact
caus
artifici
natur
liquid
inoculum
use
vitro
studi
confirm
liquidbas
inocul
virus
moi
led
product
replic
primari
human
alveolar
cell
fig
c
expos
alveolar
cell
multipl
concentr
three
virus
time
aerosol
rout
viru
highli
infecti
replic
product
well
expos
averag
pfu
contrast
replic
virus
could
detect
dose
test
follow
aerosol
inocul
fig
repetit
highestdos
aerosol
inocul
confirm
absenc
detect
replic
viru
fig
low
level
viru
present
cell
supernat
three
triplic
well
case
titer
peak
h
postinfect
declin
thereaft
indic
unsustain
unproduct
replic
determin
whether
lack
replic
product
inocul
rout
dose
expos
cell
liquid
inoculum
moi
equival
concentr
aerosol
inocul
growth
kinet
similar
observ
moi
infect
suggest
lack
replic
permiss
cell
type
could
attribut
aerosol
deliveri
viru
low
concentr
order
reach
suscept
cell
inhal
pathogen
must
penetr
mucu
layer
coat
airway
epithelium
mucu
layer
epithelium
simul
vitro
cultur
respiratori
cell
line
primari
cell
airliquid
interfac
ali
media
present
basolater
side
monolay
apic
side
left
expos
air
cultur
ali
caus
cell
differenti
form
pseudostratifi
columnar
epithelium
compris
multipl
cell
type
includ
mucussecret
goblet
cell
kreft
et
al
howev
previous
possibl
recreat
interact
aerosol
pathogen
respiratori
mucu
vitro
set
therefor
compar
suscept
cell
grown
ali
liquidliquid
interfac
lli
media
present
apic
basolater
side
infect
aerosol
viru
infect
cell
cultur
ali
three
week
suffici
induc
substanti
mucu
product
haghi
et
al
kreft
et
al
vari
viru
fig
infect
slightli
abrog
id
increas
wherea
time
less
infecti
alicultur
cell
cultur
lli
cell
success
infect
virus
replic
delay
reach
lower
titer
ali
cultur
compar
lli
fig
togeth
data
demonstr
capac
aerosol
inocula
infect
cultur
differenti
hm
creager
et
al
virolog
human
airway
cell
abrog
elimin
presenc
mucin
layer
grow
bodi
work
describ
characterist
aerosol
microb
interact
pathogenladen
aerosol
airway
epithelium
specif
examin
demonstr
infect
adher
cell
monolay
aerosol
feasibl
describ
valid
straightforward
method
calcul
exposur
dose
facilit
comparison
infect
use
liquid
aerosol
inocula
vitro
replic
studi
typic
measur
viral
titer
time
infect
singl
moi
found
measur
viral
infect
varieti
moi
inform
measur
infect
may
also
relev
viru
transmiss
interestingli
found
cultur
cell
postaerosolinocul
significantli
reduc
abil
virus
test
establish
infect
perform
liquid
comparison
would
expect
compar
result
given
consist
replic
test
virus
cell
type
import
note
howev
three
virus
lysin
posit
gene
rather
glutam
known
restrict
replic
temperatur
neumann
kawaoka
signific
effect
infect
might
observ
virus
glutam
posit
cell
type
studi
util
low
moi
may
play
import
role
advanc
understand
influenza
viru
transmiss
simul
vitro
condit
infect
first
establish
new
human
host
decreas
moi
exampl
rate
semiinfecti
particl
abl
replic
synergist
cellular
coinfect
reduc
fonvil
et
al
diminish
prolifer
defect
interf
particl
may
lessen
innat
immun
activ
therebi
allow
increas
viral
replic
inde
previous
publish
work
influenza
virus
describ
differ
viral
replic
high
low
moi
aggarw
et
al
huh
et
al
miller
et
al
demonstr
feasibl
studi
use
low
moi
though
observ
subtl
chang
replic
kinet
moi
decreas
similar
across
virus
test
pronounc
effect
may
observ
virus
cell
type
cultur
condit
eg
temperatur
droplet
nuclei
contain
viru
unlik
larger
droplet
viru
present
surfac
reach
lower
respiratori
tract
inhal
berub
et
al
therefor
particularli
interest
abil
aerosol
viru
infect
primari
human
alveolar
cell
found
season
viru
panama
fig
infect
replic
cell
aerosol
exposur
peak
viral
titer
detect
well
inocul
via
aerosol
rout
titer
log
pfuml
provid
well
show
evid
product
replic
defin
infecti
viru
detect
two
sequenti
timepoint
h
alon
full
replic
curv
shown
fig
exposur
dose
pfu
vari
slightli
virus
therefor
list
rang
exact
exposur
dose
viru
list
tabl
cell
cultur
expos
concurr
cid
indic
cellular
infecti
dose
moi
requir
achiev
infect
calcul
divid
id
cell
number
limit
detect
pfu
b
comparison
viral
supernat
titer
left
axi
copi
number
right
axi
present
cell
monolay
aerosol
liquid
inocul
h
pi
cell
cultur
supernat
collect
immedi
prior
lysi
cell
monolay
rna
collect
paramet
express
mean
standard
deviat
two
independ
well
limit
detect
segment
rna
copi
concord
observ
expect
infect
rate
well
expos
aerosol
rout
dose
near
pfu
determin
use
poisson
binomi
distribut
n
number
expos
well
p
probabl
exposur
dose
pfu
exposur
dose
follow
binomi
distribut
n
total
virion
p
well
surfac
areachamb
crosssect
area
onesid
pvalu
reflect
statist
signific
differ
number
well
expect
observ
infect
calcul
use
poisson
binomi
distribut
describ
e
power
detect
halflog
greater
differ
calcul
actual
exposur
dose
hm
creager
et
al
virolog
outbreakassoci
viru
replic
product
primari
human
pneumocyt
inocul
via
liquid
aerosol
rout
wherea
viru
highli
infecti
replic
high
titer
regardless
inocul
method
viru
vitro
result
consist
ferret
studi
detect
viru
replic
lung
human
season
viru
infect
typic
limit
upper
respiratori
tract
contrast
sever
human
case
character
symptom
lung
infect
gao
et
al
hu
et
al
yang
et
al
yu
et
al
viru
detect
lung
experiment
infect
anim
belser
et
al
de
wit
et
al
gabbard
et
al
watanab
et
al
xu
et
al
zhang
et
al
zhu
et
al
find
rais
possibl
develop
viral
pneumonia
associ
viru
develop
upon
initi
exposur
subsequ
viral
spread
adjac
tissu
warrant
investig
regard
dynam
viru
infect
throughout
respiratori
tract
need
spread
may
provid
window
opportun
immun
system
restrict
viru
caus
sever
diseas
would
explain
appar
preval
clinic
inappar
mild
infect
viru
ip
et
al
yu
et
al
use
cell
line
demonstr
growth
ali
condit
reduc
effici
initi
infect
subsequ
viral
replic
high
viscos
mucu
abund
virusbind
sialic
acid
may
limit
diffus
viru
cell
therebi
reduc
viral
titer
notabl
abrog
infect
result
cultur
ali
pronounc
two
avian
virus
test
season
viru
find
consist
hypothesi
respiratori
mucu
serv
import
barrier
abil
avian
influenza
virus
transmit
human
possibl
specif
sialic
acid
make
suscept
bind
entrap
mucu
studi
suggest
contain
glycan
primarili
conform
baum
paulson
couceiro
et
al
use
revers
genet
techniqu
compar
virus
differ
sialic
acid
bind
prefer
hemagglutinin
andor
neuraminidas
protein
allow
investig
phenomenon
aerosol
inocul
particularli
use
conjunct
increasingli
sophist
techniqu
vitro
cell
cultur
offer
uniqu
opportun
studi
viruscel
interact
environ
resembl
human
respiratori
tract
studi
suggest
aerosol
inocul
may
enhanc
studi
viral
tropism
improv
understand
effect
environment
condit
abil
influenza
viru
initi
infect
continu
investig
regard
role
inocul
rout
viral
bind
entri
process
understand
infect
influenza
virus
distinct
phenotyp
addit
influenza
method
outlin
could
use
studi
respiratori
virus
sever
acut
respiratori
syndrom
sar
viru
varicella
zoster
viru
vzv
measl
viru
well
risk
assess
novel
pathogen
abil
combin
aerosol
inocul
benefit
vitro
studi
notabl
abil
studi
specif
cell
type
isol
facilit
greater
understand
infect
tropism
respiratori
pathogen
public
health
fig
replic
influenza
virus
primari
human
alveolar
epitheli
cell
peak
viral
titer
detect
well
inocul
via
aerosol
rout
describ
legend
fig
b
replic
curv
aerosol
inocul
shown
panel
titer
shown
repres
mean
standard
deviat
three
well
c
comparison
replic
kinet
subsequ
aerosol
liquid
inocul
human
primari
alveolar
epitheli
cell
cell
infect
aerosol
rout
solid
black
line
tradit
liquid
rout
dot
line
moi
gray
black
aerosol
moi
virus
respect
cultur
supernat
collect
indic
time
pi
titer
determin
standard
plaqu
assay
quantifi
infecti
viru
limit
detect
pfu
mean
sd
triplic
cultur
duplic
liquid
inoculum
moi
shown
tabl
cell
cultur
lli
ali
expos
concurr
therefor
ident
exposur
dose
b
replic
curv
well
expos
pfu
shown
panel
cultur
supernat
collect
indic
time
pi
titer
determin
standard
plaqu
assay
quantifi
infecti
viru
limit
detect
pfu
titer
shown
repres
mean
standard
deviat
three
well
two
case
twoway
anova
show
overal
titer
differ
cell
cultur
lli
ali
statist
signific
p
viru
titer
lli
ali
well
compar
individu
timepoint
pvalu
adjust
multipl
comparison
use
bonferroni
correct
indic
p
indic
p
hm
creager
et
al
virolog
